Skip to content

    Yasho Industries Limited

    YASHO
    Chemicals·7 Nov 2025
    Management Summary

    Yasho Industries reported a resilient Q2 FY26 amidst a challenging external environment marked by tariff pressures and slow demand. While H1 revenue grew 11.8% YoY with strong volume, Q2 saw sequential revenue dip due to pricing pressure. The company achieved an 18.2% EBITDA margin and commissioned a new R&D lab, alongside securing a significant long-term supply agreement. Management revised FY26 revenue guidance to INR 800-850 crores, down from previous estimates, acknowledging tariff impacts and inventory buildup.

    Highlights

    5
    • H1 FY26 Revenue grew 11.8% YoY to INR 382.6 crores, driven by strong 30% volume growth.

    • Q2 FY26 Revenue increased 9.6% YoY to INR 183.6 crores, achieving an EBITDA margin of 18.2%.

    • Secured a 15-year long-term supply agreement for lubricant derivatives, projected to add INR 150 crores in annual revenue from FY27.

    • Successfully commissioned a new R&D laboratory with an investment of INR 23 crores, enhancing innovation capabilities.

    • Management is focused on maintaining healthy EBITDA margins (17-19% for FY27) despite external challenges.

    Concerns

    5
    • Pakhajan facility operated below optimal utilization (<50%) in Q2 due to trade restrictions in key export markets.

    • Revenue was marginally lower sequentially in Q2 due to pricing pressure and deferred export orders linked to tariffs.

    • Temporary increase in working capital and gross debt due to inventory buildup triggered by tariff-related export delays.

    • Revised FY26 revenue guidance downwards from INR 900-1000 crores to INR 800-850 crores due to the impact of tariffs.

    • US sales took a hit in Q2, with 40% of the 25% US business affected by tariffs.

    What Changed1

    vs Q3 FY26

    Guidance items11 → 13 (+2)
    Key financials

    Metrics

    5

    Periods

    2

    Headline

    2
    • H1 FY26 Revenue
      ₹382.6 Cr
      YoY+11.8%
    • H1 FY26 Volume Growth
      30%

    Q2 FY26

    3
    • Revenue
      ₹183.6 Cr
      YoY+9.6%
    • EBITDA Margin
      18.2%
    • PAT Margin
      2.6%

    Segment breakdown

    Industrial Segment
    84% Revenue Contribution
    List

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    ₹100 crores

    Debt

    3.5x EBITDA

    Guidance & targets

    13
    CategoryTargetPriority
    Revenue
    FY26 Revenue
    INR 800-850 crores
    Medium
    Revenue
    Annual Revenue from MNC Contract
    INR 150 crores
    High
    Profitability
    FY27 EBITDA Margin
    17-19%
    High
    Asset Efficiency
    Asset Turnover Ratio
    3x
    Medium
    Working Capital
    Inventory Days
    160-175 days
    High
    Working Capital
    Receivables Days
    60-70 days
    High
    R&D Spend
    FY26 R&D Opex
    INR 5 crores
    High
    R&D Spend
    FY27 R&D Opex
    INR 8-10 crores
    High
    Export Mix
    Export Sales as % of Total Revenue
    70%
    Medium
    New Customer Contribution
    New Customer Revenue Contribution to FY26
    10-15%
    Medium
    Capacity
    Optimal Capacity Revenue
    INR 1,200 crores
    High
    Capex
    Revenue from INR 75 crores Capex
    INR 250 crores
    High
    Capex
    Time to achieve INR 250 crores revenue from INR 75 crores capex
    12-24 months
    Medium

    Pakhajan facility utilization level

    coming quarters
    CurrentBelow 50%
    TargetImproved utilization

    Why it matters

    Improvement in utilization is key to operational efficiency and profitability, especially given current underperformance.

    We expect utilization level to steadily improve over the coming quarters.

    How to verify

    key_financials.metrics[label='Capacity Utilization']

    Risks & concerns

    4
    RiskSeverity

    Tariff pressures and slow demand

    Complex external environment with tariff pressures and slow demand across several key markets, leading to revised revenue guidance and impact on US sales.Management acknowledged

    high

    Pakhajan facility underutilization

    Pakhajan facility operated below optimal utilization (<50%) in Q2 due to trade restrictions in key export markets.Management acknowledged

    medium

    Inventory buildup and working capital strain

    Temporary increase in working capital and gross debt due to inventory buildup triggered by tariff-related export delays.Management acknowledged

    medium

    Chinese competition/dumping

    Intense competition from China is putting pressure on certain chemistries, affecting the business.Analyst acknowledged

    medium

    Q&A highlights

    8

    “our capability on a technical side, that has given a confidence to our customer that we can deliver the product what they are looking at, which is very complex and critical for their application... So we requested for fund. So they have committed here to recover the cost, their cost.”

    Analyst questioned the unusual nature of a customer funding vendor capex, and management clarified it's due to Yasho's technical capability for complex products and a cost recovery arrangement.

    asked by Pujan Shah

    2 min read5 chapters

    Detailed Narrative

    01

    Q2 & H1 FY26 Performance Amidst External Headwinds

    Yasho Industries reported H1 FY26 revenue of INR 382.6 crores, marking an 11.8% year-on-year growth, significantly supported by a strong 30% volume growth. However, Q2 FY26 revenue was marginally lower sequentially at INR 183.6 crores, though still up 9.6% YoY, primarily due to pricing pressure and deferred export orders linked to tariffs. Despite these challenges, the company maintained profitability with an EBITDA margin of 18.2% and a PAT margin of 2.65% for Q2 FY26, attributed to operating discipline and improved product mix.

    02

    Strategic Growth Initiatives and Capacity Expansion

    The company achieved two key strategic milestones: signing a 15-year long-term supply agreement with a global MNC for lubricant derivatives, expected to generate approximately INR 150 crores in annual revenue from FY27, with the associated plant becoming operational by Q4 FY27. Additionally, a new R&D laboratory was successfully commissioned on October 29, 2025, following an investment of INR 23 crores. This R&D focus aims to drive innovation-led growth, with R&D opex projected to increase from INR 1 crore previously to INR 5 crores in FY26 and INR 8-10 crores in FY27.

    03

    Impact of Tariffs and Market Diversification

    The external environment, particularly tariff pressures🌐 and slow demand in key export markets like the US, significantly impacted operations. Approximately 40% of the 25% US business was affected by tariffs, leading to Pakhajan facility operating below optimal utilization (below 50%) in Q2. To mitigate this, Yasho is actively exploring alternate geographies and engaging with customers to regain business. Management expects exports to constitute almost 70% of total revenue within 6-18 months, indicating a strategic shift towards diversification.

    04

    Financial Health and Capital Allocation Strategy

    Working capital and gross debt saw a temporary increase in Q2 due to inventory buildup from tariff-related export delays. However, management is focused on normalizing cash flows and optimizing inventory, aiming to reduce inventory days from 210 to 160-175 by March. The company has no intention to reduce absolute debt but targets a debt-to-EBITDA ratio of 3-3.5 by FY27, driven by EBITDA growth. Long-term debt repayments commenced in April 2025.

    05

    Revised FY26 Outlook and Future Capex Plans

    Due to the ongoing tariff issues, Yasho Industries revised its FY26 revenue guidance downwards from INR 900-1000 crores to INR 800-850 crores. While INR 23 crores were spent on the R&D lab and INR 20 crores on existing capacity expansion, INR 45 crores of planned capex for the current year remains unspent, awaiting clarity on the business climate. New capex for the MNC project is estimated at INR 50-75 crores, expected to generate INR 250 crores in revenue within 12-24 months of becoming operational.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.